SCIB SciBase Holding AB (publ)

0.9036USD9.180 SEK · STO+0.88%Mkt Cap: 12.76M USDP/E: —

SciBase Holding AB (publ), a medical technology company, develops and commercializes point-of-care platforms for skin health management in Europe, the United States, North America, Asia, Oceania, and internationally. It …

Key Statistics

Company
Market Cap12.76M USD
Enterprise Value10.12M USD
Revenue (TTM)5.58M USD
Gross Profit2.67M USD
Net Income (TTM)-8.57M USD
Revenue/Share0.68 USD
Last Price0.9036 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees46
CountrySE
SectorHealthcare
IndustryMedical Devices
ISINSE0029277631
Valuation
P/E (Trailing)—
P/E (Forward)-57.38
PEG—
EV/EBITDA-1.01
EV/Revenue1.81
P/S2.29
P/B16.66
EPS (TTM)-1.42 USD
EPS (Forward)-0.02 USD
52W Range
0.87211% of range5.315
52W High5.315 USD
52W Low0.8721 USD
Profitability
Gross Margin66.99%
Oper. Margin-183.13%
EBITDA Margin-179.94%
Profit Margin-215.18%
ROE-1307.84%
ROA-166.89%
ROIC-1202.70%
ROCE-313.19%
Growth
Revenue Growth41.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-8.33M USD
CapEx (TTM)22.44K USD
FCF Margin-135.70%
FCF Yield-59.34%
Net Debt882.62K USD
Net Debt/EBITDA-0.09
Net Debt/FCF—
Balance Sheet
Debt/Equity3.46
Current Ratio1.83
Quick Ratio1.26
Book Value/Sh0.05 USD
Cash/Share0.13 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:100
Split DateJun 4, 2026
Analyst Consensus
Rating0.0 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)2.854 USD
Upside (mean)+215.9%
Target Range2.854 USD – 2.854 USD
# Analysts1
Ownership
Shares Out.14.12M
Float8.92M
Insiders47.03%
Institutions8.32%
Technical
SMA 501.342 (-32.7%)
SMA 2002.866 (-68.5%)
Beta—
S&P 52W Chg12.00%
Avg Vol (30d)18.01K
Avg Vol (10d)28.17K
Technical Indicators
RSI (14)20.2
MACD-1.3845
MACD Signal-1.2662
MACD Hist.-0.1183
BB Upper1.389 USD
BB Middle1.114 USD
BB Lower0.8384 USD
BB Width49.44%
ATR (14)0.0736 USD
Vol Ratio (20d)0.18x

About SciBase Holding (STO: SCIB)

›

SciBase Holding (STO: SCIB) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 46 employees.

The shares were at 9.180 SEK on 19 November 2026, down 62.2% over 52 weeks. Its 52-week range is 8.860 SEK to 54.00 SEK: the price is 83.0% below the high and 3.6% above the low.

Its market capitalisation is 129.62M SEK.

SciBase Holding reports an operating margin of -183.1% and revenue up 41.4% year over year.

Its debt exceeds its cash by 8.97M SEK, a debt-to-equity ratio of 3.46. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health. One analyst covers the stock; their mean price target of 29.00 SEK is 215.9% above the current price.